Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 AUD | 0.00% | -2.17% | +30.43% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+30.43% | 59.71M | |
-11.37% | 156M | |
-14.72% | 81.85M |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023